{"id":"https://openalex.org/W2034416686","doi":"https://doi.org/10.1038/clpt.2010.11","title":"Regional P-Glycoprotein Activity and Inhibition at the Human Blood\u2013Brain Barrier as Imaged by Positron Emission Tomography","display_name":"Regional P-Glycoprotein Activity and Inhibition at the Human Blood\u2013Brain Barrier as Imaged by Positron Emission Tomography","publication_year":2010,"publication_date":"2010-03-24","ids":{"openalex":"https://openalex.org/W2034416686","doi":"https://doi.org/10.1038/clpt.2010.11","mag":"2034416686","pmid":"https://pubmed.ncbi.nlm.nih.gov/20336065","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2939015"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2010.11","doi":"https://doi.org/10.1038/clpt.2010.11","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2010.11","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2939015","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040526869","display_name":"Sara Eyal","orcid":"https://orcid.org/0000-0003-1275-6094","observed_orcids":["https://orcid.org/0000-0003-1275-6094"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Eyal","raw_affiliation_strings":["Department of Pharmaceutics, University of Washington, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039299908","display_name":"Ban Ke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Ke","raw_affiliation_strings":["Department of Pharmaceutics, University of Washington, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045511356","display_name":"Mark Muzi","orcid":"https://orcid.org/0000-0002-8767-191X","observed_orcids":["https://orcid.org/0000-0002-8767-191X"]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Muzi","raw_affiliation_strings":["Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA","institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109208765","display_name":"J. M. Link","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J M Link","raw_affiliation_strings":["Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA","institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072312981","display_name":"David A. Mankoff","orcid":"https://orcid.org/0000-0002-6971-5413","observed_orcids":["https://orcid.org/0000-0002-6971-5413"]},"institutions":[{"id":"https://openalex.org/I1332479046","display_name":"Seattle Cancer Care Alliance","ror":"https://ror.org/03jq88n71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1332479046"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D A Mankoff","raw_affiliation_strings":["Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA","institution_ids":["https://openalex.org/I1332479046","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103275476","display_name":"Ann C. Collier","orcid":"https://orcid.org/0000-0001-5673-0422","observed_orcids":["https://orcid.org/0000-0001-5673-0422"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A C Collier","raw_affiliation_strings":["Department of Medicine, University of Washington, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020600016","display_name":"Jashvant D. Unadkat","orcid":"https://orcid.org/0000-0002-4820-8455","observed_orcids":["https://orcid.org/0000-0002-4820-8455"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J D Unadkat","raw_affiliation_strings":["Department of Pharmaceutics, University of Washington, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.8332,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.91114935,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"87","issue":"5","first_page":"579","last_page":"585"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9959999918937683},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.8769999742507935},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9449999928474426},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibition","display_name":"P-glycoprotein inhibition","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-distribution-in-brain","display_name":"brain drug distribution","score":0.7350000143051147},{"id":"https://openalex.org/keywords/regional-cerebral-blood-flow","display_name":"regional cerebral blood flow","score":0.7760000228881836},{"id":"https://openalex.org/keywords/gray-and-white-matter","display_name":"gray and white matter","score":0.7590000033378601},{"id":"https://openalex.org/keywords/pituitary-gland","display_name":"pituitary gland","score":0.7509999871253967},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.7149853706359863},{"id":"https://openalex.org/C157767197","wikidata":"https://www.wikidata.org/wiki/Q886843","display_name":"Cerebral blood flow","level":2,"score":0.6850908994674683},{"id":"https://openalex.org/C2781192897","wikidata":"https://www.wikidata.org/wiki/Q822050","display_name":"White matter","level":3,"score":0.6844131946563721},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.6407155394554138},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.6092721819877625},{"id":"https://openalex.org/C2777670902","wikidata":"https://www.wikidata.org/wiki/Q492038","display_name":"Human brain","level":2,"score":0.5239032506942749},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.514197587966919},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5056023597717285},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49537408351898193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41648536920547485},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.4128872752189636},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3697676956653595},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3385222554206848},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24809667468070984},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2222507894039154},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.2096671760082245},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.19762453436851501},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.14023032784461975},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07894906401634216},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.0},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018435","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/clpt.2010.11","doi":"https://doi.org/10.1038/clpt.2010.11","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2010.11","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:20336065","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20336065","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:2939015","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2939015","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2939015","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2939015","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G255753792","display_name":"P-glycoprotein and Alzheimer's Disease","funder_award_id":"R33AG031485","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1594196316","https://openalex.org/W1598654033","https://openalex.org/W1968468976","https://openalex.org/W1970199708","https://openalex.org/W1986992211","https://openalex.org/W1987405059","https://openalex.org/W1988545739","https://openalex.org/W1994626354","https://openalex.org/W1995807988","https://openalex.org/W2001408101","https://openalex.org/W2008430084","https://openalex.org/W2018959949","https://openalex.org/W2046343072","https://openalex.org/W2046826638","https://openalex.org/W2047409028","https://openalex.org/W2047853787","https://openalex.org/W2048495467","https://openalex.org/W2049892216","https://openalex.org/W2052329451","https://openalex.org/W2056080810","https://openalex.org/W2057004544","https://openalex.org/W2058864686","https://openalex.org/W2061928059","https://openalex.org/W2069118421","https://openalex.org/W2070587942","https://openalex.org/W2083673453","https://openalex.org/W2087340189","https://openalex.org/W2096084239","https://openalex.org/W2098307651","https://openalex.org/W2115609442","https://openalex.org/W2126487804","https://openalex.org/W2129122317","https://openalex.org/W2133475198","https://openalex.org/W2136564762","https://openalex.org/W2140293712","https://openalex.org/W2142878553","https://openalex.org/W2144239482","https://openalex.org/W2148776940","https://openalex.org/W2149624936","https://openalex.org/W2157393167","https://openalex.org/W2162010696","https://openalex.org/W2162438271","https://openalex.org/W2163209521","https://openalex.org/W2166015457","https://openalex.org/W2168239564","https://openalex.org/W2171664964","https://openalex.org/W2402259942","https://openalex.org/W2417452057"],"related_works":["https://openalex.org/W2140293712","https://openalex.org/W2056477521","https://openalex.org/W2020254797","https://openalex.org/W2144239482","https://openalex.org/W2168239564","https://openalex.org/W2070613307","https://openalex.org/W2925110659","https://openalex.org/W436696293","https://openalex.org/W7098132680","https://openalex.org/W2163405722"],"abstract_inverted_index":{"We":[0],"used":[1],"positron":[2],"emission":[3],"tomography":[4],"(PET)":[5],"to":[6,20,62,105],"evaluate":[7],"the":[8,15,25,52,59,63,76,81,100,113,116,122,125,148,159,165],"contribution":[9],"of":[10,55,75,95,129,150],"P-glycoprotein":[11],"(P-gp),":[12],"present":[13],"at":[14],"human":[16],"blood-brain":[17],"barrier":[18],"(BBB),":[19],"regional":[21,64],"drug":[22],"distribution":[23,149],"in":[24,51,58,80,102,158],"brain.":[26],"Eleven":[27],"healthy":[28],"volunteers":[29],"underwent":[30],"PET":[31],"imaging":[32],"with":[33],"[(11)C]-verapamil":[34],"before":[35],"and":[36,78,108,143,156],"during":[37],"cyclosporine":[38,47],"A":[39],"infusion.":[40],"Regional":[41],"P-gp":[42,130,142],"inhibition":[43,131,145],"was":[44,132],"expressed":[45],"as":[46],"A-induced":[48],"percentage":[49],"change":[50],"distributional":[53],"clearance":[54],"verapamil":[56],"(K(1))":[57],"brain,":[60],"normalized":[61],"blood":[65],"flow":[66],"(rCBF).":[67],"K(1)":[68,96,114],"estimates":[69,88,103],"were":[70,89],"similar":[71],"across":[72,134],"gray-matter":[73],"regions":[74,162],"brain":[77,136,161],"lower":[79,91],"white":[82,109],"matter":[83,107],"regions,":[84],"but":[85],"all":[86],"these":[87],"considerably":[90],"than":[92],"rCBF.":[93,126],"Normalization":[94],"by":[97,164],"rCBF":[98],"diminished":[99],"differences":[101],"related":[104],"gray":[106],"matter.":[110],"In":[111],"contrast,":[112],"for":[115],"pituitary,":[117],"which":[118],"is":[119],"situated":[120],"outside":[121],"BBB,":[123],"approximated":[124],"The":[127],"magnitude":[128],"comparable":[133],"BBB-protected":[135],"structures.":[137],"Our":[138],"results":[139],"indicate":[140],"that":[141],"its":[144],"equally":[146],"affect":[147],"drugs":[151],"(and":[152],"therefore":[153],"their":[154],"neuro-efficacy":[155],"toxicity)":[157],"various":[160],"protected":[163],"BBB.":[166]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}